Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03978442Phase 4Completed
Phase 4, randomised, open-label trial in Tobacco Use Disorder (TUD) and post-traumatic stress disorder (PTSD) (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Number of Participants Whose Self-report of 7 Day Point Prevalence Abstinence From Smoking is Bioverified at 6 months. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03978442.